本页面由Tiger Trade Technology Pte. Ltd.提供服务

Anebulo Pharmaceuticals Inc

0.3000
0.0000
成交量:117
成交额:30.00
市值:1,223.54万
市盈率:-1.54
高:0.3000
开:0.3000
低:0.3000
收:0.3000
52周最高:2.90
52周最低:0.0004
股本:4,078.47万
流通股本:340.13万
量比:0.42
换手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-0.1945
每股收益(LYR):-0.2509
净资产收益率:-69.69%
总资产收益率:-45.04%
市净率:1.54
市盈率(LYR):-1.20

数据加载中...

2026/02/17

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2026/02/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/13

重要事件披露

Form 8-K - Current report
2026/02/06

重要事件披露

Form 8-K - Current report
2026/01/29

重要事件披露

Form 8-K - Current report
2026/01/27

私有化交易

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2026/01/27

重要事件披露

Form 8-K - Current report
2025/12/22

私有化交易

Form SC TO-I - Tender offer statement by Issuer
2025/12/22

重要事件披露

Form 8-K - Current report
2025/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/14

重要事件披露

Form 8-K - Current report
2025/10/11

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2025/09/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/09/29

重要事件披露

Form 8-K - Current report
2025/09/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/09/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/09/15

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2025/09/12

重要事件披露

Form 8-K - Current report
2025/07/23

重要事件披露

Form 8-K - Current report
2025/07/23

私有化交易

Form SC 13E3 - Going private transaction by certain issuers